{
    "2021-12-23": [
        [
            {
                "time": "2021-11-19",
                "original_text": "U.S. pauses allocation of Regeneron, Lilly COVID-19 antibodies",
                "features": {
                    "keywords": [
                        "U.S.",
                        "pauses",
                        "Regeneron",
                        "Lilly",
                        "COVID-19",
                        "antibodies"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-12-01",
                "original_text": "3 Unstoppable Stocks to Buy for 2022",
                "features": {
                    "keywords": [
                        "Unstoppable",
                        "Stocks",
                        "Buy",
                        "2022"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-22",
                "original_text": "Pfizer (PFE) Gets FDA's Emergency Use Nod for COVID Pill",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "FDA",
                        "Emergency",
                        "Use",
                        "Nod",
                        "COVID",
                        "Pill"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-11-25",
                "original_text": "MainStay VP Wellington U.S. Equity Portfolio Buys VF Corp, Seagen Inc, Sells Under Armour Inc, ...",
                "features": {
                    "keywords": [
                        "MainStay",
                        "VP",
                        "Wellington",
                        "U.S.",
                        "Equity",
                        "Portfolio",
                        "Buys",
                        "VF",
                        "Corp",
                        "Seagen",
                        "Inc",
                        "Sells",
                        "Under",
                        "Armour",
                        "Inc"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "consumer goods",
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2021-11-23",
                "original_text": "The Zacks Analyst Blog Highlights: Microsoft, Broadcom, Eli Lilly, Intuitive Surgical and MetLife",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "Highlights",
                        "Microsoft",
                        "Broadcom",
                        "Eli",
                        "Lilly",
                        "Intuitive",
                        "Surgical",
                        "MetLife"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "healthcare",
                        "insurance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}